Følg
Søren Møller
Søren Møller
Hvidovre Hospital
Verificeret mail på regionh.dk
Titel
Citeret af
Citeret af
År
Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease
S Møller, JH Henriksen
Heart 87 (1), 9-15, 2002
890*2002
Cardiovascular complications of cirrhosis
S Møller, JH Henriksen
Postgraduate medical journal 85 (999), 44-54, 2009
6282009
Bacterial translocation and cardiovascular complications of cirrhosis. Authors' response to letter
S Møller, JH Henriksen
Gut 57, 1181-1182, 2008
628*2008
Cirrhotic cardiomyopathy
S Møller, JH Henriksen
Journal of hepatology 53 (1), 179-190, 2010
4672010
Interactions of the heart and the liver
S Møller, M Bernardi
European heart journal 34 (36), 2804-2811, 2013
4562013
Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites
A Krag, F Bendtsen, JH Henriksen, S Møller
Gut 59 (01), 105-110, 2010
4532010
Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity …
JH Henriksen, JP Gøtze, S Fuglsang, E Christensen, F Bendtsen, S Møller
Gut 52 (10), 1511-1517, 2003
3322003
Serum YKL-40 is increased in patients with hepatic fibrosis
JS Johansen, P Christoffersen, S Møller, PA Price, JH Henriksen, ...
Journal of hepatology 32 (6), 911-920, 2000
3272000
Cirrhotic cardiomyopathy: pathogenesis and clinical relevance
S Wiese, JD Hove, F Bendtsen, S Møller
Nature reviews Gastroenterology & hepatology 11 (3), 177, 2014
2952014
Systematic review with meta‐analysis: the effects of rifaximin in hepatic encephalopathy
N Kimer, A Krag, S Møller, F Bendtsen, LL Gluud
Alimentary pharmacology & therapeutics 40 (2), 123-132, 2014
2172014
The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis
S Møller, F Bendtsen
Liver International 38 (4), 570-580, 2018
1922018
The sympathetic nervous system in liver disease
JH Henriksen, S Møller, H Ring-Larsen, NJ Christensen
Journal of hepatology 29 (2), 328-341, 1998
1911998
Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients
S Møller, EF Hansen, U Becker, K Brinch, JH Henriksen, F Bendtsen
Liver 20 (1), 51-59, 2000
1832000
Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome
A Krag, S Møller, JH Henriksen, NH Holstein‐Rathlou, FS Larsen, ...
Hepatology 46 (6), 1863-1871, 2007
1782007
Dyssynchronous electrical and mechanical systole in patients with cirrhosis
JH Henriksen, S Fuglsang, F Bendtsen, E Christensen, S Møller
Journal of hepatology 36 (4), 513-520, 2002
1742002
Soluble CD 163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis
H Grønbaek, TD Sandahl, C Mortensen, H Vilstrup, HJ Møller, S Møller
Alimentary pharmacology & therapeutics 36 (2), 173-180, 2012
1712012
Acute non-selective β-adrenergic blockade reduces prolonged frequency-adjusted Q–T interval (QTc) in patients with cirrhosis
JH Henriksen, F Bendtsen, EF Hansen, S Møller
Journal of hepatology 40 (2), 239-246, 2004
1712004
Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis
S Møller, F Bendtsen, JH Henriksen
Gastroenterology 109 (6), 1917-1925, 1995
1561995
Lactate metabolism in chronic liver disease
JB Jeppesen, C Mortensen, F Bendtsen, S Møller
Scandinavian journal of clinical and laboratory investigation 73 (4), 293-299, 2013
1522013
Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?
JS Johansen, S Møller, PA Price, F Bendtsen, J Junge, C Garbarsch, ...
Scandinavian journal of gastroenterology 32 (6), 582-590, 1997
1501997
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20